Use of adenovirus vectors for functional gene analysis in the chicken chorioallantoic membrane

BioTechniques

Volumn 34, Issue 1, 2003, Pages 178-183

  Schughart, Klaus ^a,b   Accart, Nathalie ^a  

^a TRANSGENE S A   (France)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSELS; CELLS; GENE TRANSFER; PROTEINS; PURIFICATION;

ADENOVIRUS VECTORS;

GENES;

ADENOVIRUS VECTOR; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ADENOVIRUS 5; ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CHICKEN; CHORIOALLANTOIS; CONTROLLED STUDY; GENE EXPRESSION; GENE TRANSFER; HISTOLOGY; ISCHEMIA; NONHUMAN; REPORTER GENE; TRANSGENE; TUMOR VASCULARIZATION;

ADENOVIRIDAE; ANIMALIA; DNA VIRUSES; GALLUS GALLUS; HUMAN ADENOVIRUS TYPE 5;

EID: 0037228851     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/03341dd06     Document Type: Article

References (23)

1. Cao, R., H.L. Wu, N. Veitonmaki, P. Linden, J. Farnebo, G.Y. Shi, and Y. Cao. 1999. Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis. Proc. Natl. Acad. Sci. USA 96:5728-5733.
2. Carmeliet, P. and R.K. Jain. 2000. Angiogenesis in cancer and other diseases. Nature 407:249-257.
3. Chartier, C., E. Degryse, M. Gantzer, A. Dieterle, A. Pavirani, and M. Mehtali. 1996. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J. Virol. 70:4805-4810.
4. Eichmann, A., C. Corbel, V. Nataf, P. Vaigot, C. Breant, and N.M. Le Douarin. 1997. Ligand-dependent development of the endothelial and hemopoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor 2. Proc. Natl. Acad. Sci. USA 94:5141-5146.
5. Ferrara, N. and K. Alitalo. 1999. Clinical applications of angiogenic growth factors and their inhibitors. Nat. Med. 5:1359-1364.
6. Ferrara, N. 2000. VEGF: an update on biological and therapeutic aspects. Curr. Opin. Biotechnol. 11:617-624.
7. Folkman, J. 1971. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285:1182-1186.
8. Griscelli, F., P. Gilardi-Hebenstreit, N. Hanania, W.M. Franz, P. Opolon, M. Perricaudet, and T. Ragot. 1998. Heart-specific targeting of β-galactosidase by the ventricle-specific cardiac myosin light chain 2 promoter using adenovirus vectors. Hum. Gene Ther. 9:1919-1928.
9. Iruela-Arispe, M.L., M. Lombardo, H.C. Krutzsch, J. Lawler, and D.D. Roberts. 1999. Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats. Circulation 100:1423-1431.
10. Jain, R.K., K. Schlenger, M. Hockel, and F. Yuan. 1997. Quantitative angiogenesis assays: progress and problems. Nat. Med. 3:1203-1208.
11. Krasnykh, V.N., J.T. Douglas, and V.W. van Beusechem. 2000. Genetic targeting of adenoviral vectors. Mol. Ther. 1:391-405.
12. Lusky, M., M. Christ, K. Rittner, A. Dieterle, D. Dreyer, B. Mourot, H. Schultz, F. Stoeckel, et al. 1998. In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted. J. Virol 72:2022-2032.
13. Nguyen, M., Y. Shing, and J. Folkman. 1994. Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane. Microvasc. Res. 47:31-40.
14. Pfeifer, A., T. Kessler, S. Silletti, D.A. Cheresh, and I.M. Verma. 2000. Suppression of angiogenesis by lentiviral delivery of PEX. A noncatalytic fragment of matrix metalloprotease 2. Proc. Natl. Acad. Sci. USA 97:12227-12232.
15. Ribatti, D., C. Urbinati, B. Nico, M. Rusnati, L. Roncali, and M. Presta. 1995. Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane. Dev. Biol. 170:39-49.
16. Ribatti, D., A. Vacca, L. Roncali, and F. Dammacco. 2000. The chick embryo chorioallantoic membrane as a model for in vivo research on anti-angiogenesis. Curr. Pharm. Biotechnol. 1:73-82.
17. Ribatti, D., B. Nico, L. Morbidelli, S. Donnini, M. Ziche, A. Vacca, L. Roncali, and M. Presta. 2001. Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto the chick chorioallantoic membrane: endothelial fenestration and angiogenesis. J. Vasc. Res. 38:389-397.
18. Salcedo, R., H.A. Young, M.L. Ponce, J.M. Ward, H.K. Kleinman, W.J. Murphy, and J.J. Oppenheim. 2001. Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells. J. Immunol. 166:7571-7578.
19. Schiedner, G., N. Morral, R.J. Parks, Y. Wu, S.C. Koopmans, C. Langston, F.L. Graham, A.L. Beaudet, et al. 1998. Genomic DNA transfer with a high capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. 18:180-183.
20. Schughart, K., R. Bischoff, U.B. Rasmussen, D.A. Hadji, F. Perraud, N. Accart, O. Boussif, N. Silvestre, et al. 1999. Solvoplex: a new type of synthetic vector for intrapulmonary gene delivery. Hum. Gene Ther. 10:2891-2905.
21. Stratford-Perricaudet, L.D., I. Makeh, M. Perricaudet, and P. Briand. 1992. Widespread long-term gene transfer to mouse skeletal muscles and heart. J. Clin. Invest. 90:626-630.
22. Vazquez, F., G. Hastings, M.A. Ortega, T.F. Lane, S. Oikemus, M. Lombardo, and M.L. Iruela-Arispe. 1999. METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. J. Biol. Chem. 274:23349-23357.
23. Wilting, J., B. Christ, M. Bokeloh, and H.A. Weich. 1993. In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane. Cell Tissue Res. 274:163-172.